Healthlead Stock

HL

THA598010009

Drug Retailers

End-of-day quote Thailand S.E. 2026-09-10			5-day change	1st Jan Change
4.500 ^THB	+0.45%		-3.85%	-37.50%

08-17	Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-10	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 6,000,000 shares, representing 2.21% for THB 42 million.	CI

Healthlead Public Company Limited is a Thailand-based company involved in the pharmacy business, distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products. The Company is also engaged in the invention, development, import, and distribution of healthcare products. Its businesses include Icare Health and Healthiness. Icare Health business operates pharmacies that sell more than 10,000 stock-keeping units (SKUs) of medicines, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products. Its pharmacies operate under four brands: iCare, Pharmax, Vitaminclub, and Super Drug. The Healthiness business develops its products in collaboration with external researchers. These products and innovations are marketed under two brands: PRIME and Besuto. Its brands also include BOMSKIN. The Companyâ€™s subsidiaries are Icare Health Co., Ltd. and Healthiness Co., Ltd. It operates approximately 64 branches.

Employees

Sector

Drug Retailers

More about the company

Quotes

Date	Price	Change	Volume
26-09-09	THB 4.500	+0.45%	133,418
26-09-09	THB 4.480	-0.44%	71,610
26-09-08	THB 4.500	+0.45%	135,062
26-09-07	THB 4.480	-2.61%	573,071
26-09-04	THB 4.600	-1.29%	670,768

End-of-day quote Thailand S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

Market Cap	1.14B 34.57M 29.73M 28.05M 25.56M 47.77M 3.31B 48.21M 334M 129M 1.68B 130M 127M 5.33B	P/E 2024	35.4x	P/E 2025	24.8x
Enterprise Value	912M 27.58M 23.72M 22.38M 20.39M 38.12M 2.64B 38.46M 267M 103M 1.34B 104M 101M 4.25B	EV / Sales 2024	1.27x	EV / Sales 2025	0.73x
Free-Float	22.31%	Yield 2024	1.67%	Yield 2025	3.06%

08-17	Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-10	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 6,000,000 shares, representing 2.21% for THB 42 million.	CI
05-07	Healthlead Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Healthlead Public Company Limited authorizes a Buyback Plan.	CI
04-29	Healthlead Public Company Limited's Equity Buyback announced on December 8, 2025, has expired.	CI
03-09	Healthlead Public Company Limited Announces Retirement of Rathpong Ratanahirunya as Independent Director, Effective 24 April, 2026	CI
02-25	Healthlead Public Company Limited Announces Board Changes, Effective February 26, 2026	CI
02-25	Healthlead Public Company Limited Announces CEO Changes, Effective March 1, 2026	CI
02-25	Healthlead Public Company Limited announces Annual dividend, payable on May 15, 2026	CI
02-24	Healthlead Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-08	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 9,000,000 shares, representing 3.31% for THB 65 million.	CI
12-07	Healthlead Public Company Limited authorizes a Buyback Plan.	CI
11-19	Tranche Update on Healthlead Public Company Limited (SET:HL)'s Equity Buyback Plan announced on May 15, 2025.	CI

22-05-31	Healthlead Public : Changing of Chief Accountant	PU
22-04-22	Healthlead Public : To report the resolutions of the 2022 Annual General Meeting of Shareholders	PU
22-03-31	Healthlead Public : Publication of Invitation to the 2022 Annual General Meeting of Shareholders on the Company's Website	PU

1 day	+0.45%
1 week	-3.85%
Current month	-7.02%
1 month	-20.35%
3 months	-20.35%
6 months	-34.31%
Current year	-37.50%

1 week	4.46	4.66
1 month	4.46	5.6
Current year	4.46	7.35
1 year	4.46	8.45
3 years	4.46	12.7
5 years	4.46	32
10 years	4.46	32

Healthlead Stock

Stocks

HL

THA598010009

Drug Retailers

Valuation : Healthlead

Chart: Healthlead

Latest news : Healthlead

Press Releases : Healthlead

Quotes and Performance

Price Extremes

Managers and Directors : Healthlead

Latest insider transactions

Other Drug Retailers

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

Manager	Title	Age	Since
Supakorn Bhandhukanonda CEO	Chief Executive Officer	38	2026-02-28
Araya Tantanasin DFI	Director of Finance/CFO	56	2018-12-31
Sasithon Marukasonthi AUD	Comptroller/Controller/Auditor	-	2022-08-31

Director	Title	Age	Since
Apirudee Hemajutha CHM	Chairman	70	2020-03-31
Marayad Teeratomorn BRD	Director/Board Member	57	2020-03-31
Thanasak Kulrattanarak BRD	Director/Board Member	52	2020-03-31

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
4/3/25	Supakorn Bhandhukanonda	Buy	Chief Executive Officer	42,800	0.0157%
4/2/25	Supakorn Bhandhukanonda	Buy	Chief Executive Officer	50,000	0.0184%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
HEALTHLEAD	+0.45%	-3.85%	-	-	34.54M
Average	+0.45%
Weighted average by Cap.	+0.45%

	2024	2025
Net sales	2.01B 60.87M 52.35M 49.39M 44.99M 84.11M 5.82B 84.87M 588M 226M 2.95B 229M 224M 9.38B	2.27B 68.69M 59.07M 55.74M 50.78M 94.92M 6.57B 95.78M 664M 255M 3.33B 258M 252M 10.58B
Net income	78.26M 2.37M 2.04M 1.92M 1.75M 3.27M 226M 3.3M 22.89M 8.81M 115M 8.89M 8.7M 365M	77.86M 2.36M 2.03M 1.91M 1.74M 3.26M 225M 3.29M 22.77M 8.76M 114M 8.85M 8.65M 363M
Net Debt	-220M -6.66M -5.73M -5.41M -4.92M -9.21M -637M -9.29M -64.38M -24.78M -323M -25.02M -24.47M -1.03B	-231M -6.99M -6.01M -5.67M -5.17M -9.66M -668M -9.74M -67.53M -25.99M -339M -26.24M -25.67M -1.08B